SEC Filing Summary: Big Rock Partners Acquisition Corp.
Business Context and Reporting Period
This Form 8-K was filed by Big Rock Partners Acquisition Corp. (not NRX Pharmaceuticals, Inc.) on January 16, 2019, reporting an event that occurred on January 7, 2019. The registrant is a Delaware corporation and an emerging growth company. The filing addresses a regulatory compliance issue regarding its listing on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance and listing compliance matter.
Material Changes and Events
- Nasdaq Non-Compliance Notice: On January 7, 2019, the Company received a letter from Nasdaq stating it failed to comply with Listing Rule 5620(a).
- Reason for Non-Compliance: The Company failed to hold an annual meeting of stockholders within twelve months of the end of its fiscal year ended December 31, 2017.
- Current Listing Status: The notification does not immediately impact the Company's listing. Common stock, units, rights, and warrants continue to trade under symbols BRPA, BRPAU, BRPAR, and BRPAW.
Outlook, Risks, and Management Commentary
- Compliance Plan: The Company has 45 calendar days from January 7, 2019, to submit a plan to regain compliance.
- Extension Possibility: If Nasdaq accepts the plan, the Company may receive an extension of up to 180 calendar days from the fiscal year end (until July 1, 2019) to hold the meeting.
- Appeal Process: If the plan is rejected, the Company may appeal to an independent Nasdaq Listing Qualifications Panel. Securities would remain listed pending the decision.
- Risk: There is no assurance that an appeal, if necessary, would be successful.
Investor Verification Checklist
- Verify the current trading status of BRPA, BRPAU, BRPAR, and BRPAW on Nasdaq.
- Confirm whether the Company has submitted a compliance plan to Nasdaq within the 45-day window.
- Monitor for any subsequent filings regarding the acceptance of the plan or the outcome of a potential appeal.
- Check for the scheduling of the missed annual stockholder meeting.